Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
Clinical trial NCT03689699 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03689699
- Sponsor
- Mark Stein
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2023-09-22
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.